Karyopharm Therapeutics Inc. (KPTI) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for KPTI. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 93 institutions reported holding KPTI, with 21.2 million shares worth $206.8 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| RA Capital Management, | 1,917,354 | $19M | UNCHANGED |
| Adage Capital Partners GP, | 1,521,322 | $15M | DECREASED |
| Acorn Capital Advisors | 1,518,113 | $15M | INCREASED |
| Goldman Sachs | 1,424,658 | $14M | INCREASED |
| BlackRock | 1,418,799 | $14M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Karyopharm Therapeutics Inc. on SentiSense.